Lupin gets 2 USFDA observations for Somerset facility Ruchika Sharma16 Jan 2023 1:15 PM ISTMumbai: Lupin has announced that the company has received two observations from the US Food and Drug Administration (USFDA) at the closure of...
Lupin Somerset facility gets EIR from USFDA Rahul Verma9 July 2022 6:30 PM ISTGlobal pharma major, Lupin Limited, today announced that the company has received the Establishment Inspection Report (EIR) from United States Food...
Lupin gets USFDA EIR for Somerset facility Ruchika Sharma7 July 2022 11:30 AM ISTThe USFDA has determined that the inspection classification of the facility is Voluntary Action Indicated (VAI).
